7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farao, M; Grandi, M; Marsiglio, A; Mongelli, N; Pesenti, E; Sola, F | 1 |
| Capolongo, L; Grandi, M; Moneta, D; Sola, F; Ubezio, P | 1 |
2 other study(ies) available for 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Antitumor activity of FCE 26644 a new growth-factor complexing molecule.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Distamycins; Drug Administration Schedule; Drug Resistance; Female; Fibroblast Growth Factor 2; Fibrosarcoma; Half-Life; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Suramin | 1995 |
The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Cell Cycle; Cell Division; Distamycins; Drug Synergism; Female; Growth Substances; Lymphoma, Large B-Cell, Diffuse; Mice; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |